Shanghai Pharma
60160716.130.74% ( -0.12 )
Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Shanghai Pharma(601607) the Revenue is 75.49 B (+2.74%), Miss estimate;the EBIT is 1.933 B (+28.57%), Miss estimate;the EPS is 0.29 (+52.63%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
75.49B2.74%
76.93B4.70%
-1.44B1.96%
EBITMiss expectations
1.93B28.57%
2.11B40.23%
-0.18B11.66%
EPSExceed expectations
0.2952.63%
0.260236.97%
+0.029815.66%
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 26, 2027
Estimate Revenue295.36 B
Estimate EBIT9.763 B
Estimate EPS1.4589
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly